Loading clinical trials...
Loading clinical trials...
Indiana University Dementia Screening Trial: The IU CHOICE Study
The purpose of the study is to conduct a randomized clinical trial assessing the harms and benefits of screening for dementia, compared to no screening for dementia, among 4,000 older adults, cared for in typical, primary care practices.
The objective of this proposal is to address the question of whether the benefits outweigh the harms of routine screening for dementia among older adults in primary care when the screening program is coupled with primary care practices prepared to provide care for those who screen positive. The specific aim of the study is to conduct a pragmatic randomized clinical trial assessing the harms and benefits of screening for dementia, compared to no screening for dementia, among 4,000 typical, older adults, cared for in typical, primary care practices, prepared to deliver best practices dementia care. Primary Specific Aim 1: Test the impact of dementia screening on health-related quality of life of the patient at 12 months. Primary Specific Aim 2: Test the impact of dementia screening on the mood and anxiety symptoms of patient at 1 month (i.e., primary potential harms). Secondary Aims: Estimate the cost effectiveness of dementia screening.
Age
65 - No limit years
Sex
ALL
Healthy Volunteers
No
IU Health-Primary Care Clinics
Indianapolis, Indiana, United States
Wishard Health Services-Primary Care Clinics
Indianapolis, Indiana, United States
IU Health Arnett Primary Care Clinics
West Lafayette, Indiana, United States
Start Date
October 1, 2012
Primary Completion Date
November 22, 2017
Completion Date
November 22, 2017
Last Updated
January 23, 2019
4,005
ACTUAL participants
Collaborative Dementia Care Program
BEHAVIORAL
Lead Sponsor
Indiana University
Collaborators
NCT07220668
NCT06159673
NCT07457138
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions